H1 Interim Report - The Nykredit Realkredit Group H1

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
H1 Interim Report - The Nykredit Realkredit Group

H1 Interim Report - The Nykredit Realkredit Group 1 January - 30 June 2013

  • 8% growth in core income to DKK 5,037m compared with H1/2012
  • Core earnings after impairment losses of DKK 1,233m against DKK 936m in H1/2012
  • Investment portfolio income of DKK 999m against DKK 1,533m in H1/2012
  • Profit before tax of DKK 2,006m against DKK 2,238m in H1/2012
  • Total core income grew 8% to DKK 5,037m
    • Core income from business operations increased by 1%
    • Other core income rose markedly due to positive value adjustment of financial derivatives in particular
  • In H1/2013 nominal mortgage lending and bank lending improved by almost DKK 6bn to DKK 1,164bn
    • Gross new mortgage lending came to DKK 62bn compared with an exceptionally high level of DKK 129bn in H1/2012
  • Operating costs, depreciation and amortisation, excluding special value adjustments, were down 2% to DKK 2,839m
    • Costs as a percentage of core income from business operations declined to 55.1% from 56.6% in H1/2012
  • Impairment losses on loans and advances stood at DKK 929m, equal to 0.08%
    • Impairment losses on mortgage lending came to 0.07%, which was unchanged on H1/2012
    • 75-day mortgage arrears declined from 0.57% in H1/2012 to 0.47%
    • Impairment losses on bank lending went down from 0.24% to 0.15%
  • The sale of strategic equities had a positive impact on investment portfolio income. Accordingly, the income should be seen in the context of value adjustment and reclassification of strategic equities against equity totalling a DKK 474m charge after tax.
The Nykredit Realkredit Group Financial highlights        
  H1/ H1/ Change FY
DKK million 2013 2012 % 2012
Core income 5,037 4,643 8 8,909
- from business operations 5,151 5,102 1 10,200
Operating costs, depreciation and amortisation 2,839 2,890 -2 5,776
Core earnings before impairment losses 2,162 1,927 12 3,315
Loan impairment losses 929 991 -6 2,149
Core earnings after impairment losses 1,233 936 32 1,166
Investment portfolio income 999 1,533 -35 2,444
Profit before tax 2,006 2,238 -10 3,145
Core Tier 1 capital ratio, % 16.6 14.5 - 15.8

Peter Engberg Jensen, Group Chief Executive, has the following comments: "Nykredit's positive business development continued in H1/2013, and all areas are trending in the right direction. Total core income grew by more than 8%, costs were cut by 2%, and impairment losses declined to DKK 929m, or 0.08% of total loans and advances.

Impairment losses have not exceeded 0.10% for any half-year since 2010.

Nykredit's robust capital structure includes equity of DKK 58.6bn. The development in H1/2013 was another step towards securing the equity level of DKK 70bn that the new capital rules are expected to require in 2019, based on Nykredit's existing business volume."

Contacts: Peter Engberg Jensen, Group Chief Executive, or Nels Petersen, Head of Corporate Communications, tel +45 44 55 14 70 or +45 20 22 22 72.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

MIT45 Takes a Stand Against Synthetic Kratom Practices

Updated Category News Views 248

MIT45's Firm Stance on Kratom Safety MIT45, a leading name in the kratom market, stands firmly against the irresponsible and hazardous practice of producing synthetic 7-hydroxymitragynine (7-OH). This commitment to consumer protection is especially important as products claiming to contain kratom often do not meet safety standards and could threaten public health. By...

Continue Reading
Canso Credit Income Fund Announces Special Distributions This Year

Updated Category News Views 171

Canso Credit Income Fund's Special Distributions Explained Lysander Funds Limited is excited to share important updates regarding the Canso Credit Income Fund (TSX: PBY). This announcement pertains to the special distributions being issued for various classes of units within the Fund for the tax year ending 2024. Understanding these distributions is vital for both...

Continue Reading
Blue Cross and Blue Shield of Texas Expands Community Support with Grants

Updated Category News Views 305

Blue Cross and Blue Shield of Texas Awards Community Grants Blue Cross and Blue Shield of Texas (BCBSTX) has announced an impressive investment of $2 million in community-based grants. This funding will go to 84 organizations across the state, all focused on enhancing accessibility to health services and tackling social determinants that significantly impact the...

Continue Reading
Dr. Soroush Baghdadi Enhances Pediatric Care at LuskinOIC

Updated Category News Views 338

Welcoming Dr. Soroush Baghdadi to Luskin Orthopaedic Institute The Luskin Orthopaedic Institute for Children takes great pride in announcing the addition of Dr. Soroush Baghdadi to its distinguished team of pediatric orthopaedic specialists. With an impressive background enriched by global experience and a passion for pediatric care, Dr. Baghdadi brings a promising vision...

Continue Reading
Fractyl Health to Share Q3 Results and Business Insights Soon

Updated Category News Views 115

Fractyl Health to Discuss Upcoming Financial Insights In Burlington, Massachusetts, Fractyl Health, Inc. (Nasdaq: GUTS) is preparing to unveil its financial results for the third quarter of 2025 along with business updates. This event is scheduled for a Wednesday at 4:30 PM ET, where key insights into the company’s progress will be shared. Accessing the Live Event...

Continue Reading